You are here

CMI Working Paper 94

Working Paper 94: Final "08" Series accelerated critical illness and term mortality tables

During 2016, the CMI Assurances Committee released two sets of proposed tables for consultation: accelerated critical illness in Working Paper 89 in May; and term mortality in Working Paper 92 in October. Both sets of tables are based on the experience in the years 2007 to 2010 of lives insured under term assurance policies issued by UK life insurers.

Working Paper 94 sets out the feedback received to the consultation and the Assurances Committee’s reasoning for not altering the proposed tables. It also summarises the Committee’s intentions regarding future work.

Two Excel spreadsheets are issued alongside this paper:

  • The final “08” Series assurances tables. This spreadsheet contains the final rates for both accelerated critical illness and term mortality.
  • “All offices” results for 2007-2010, comparing the experience of the stand-alone critical illness dataset with the final “08” Series accelerated critical illness tables; these results were issued in response to a request in a response to the consultation.

Note: “All offices” results (using the proposed tables) and the datasets underlying the graduations were issued alongside Working Papers 89 and 92. As the tables are unchanged, these outputs would not have changed; hence they are not being reissued.

Contact Details

If you have any questions about the CMI please email

Filter or search events

Start date
E.g., 04/03/2021
End date
E.g., 04/03/2021

Events calendar

  • Finance in the Public Interest Series

    16 March 2021 - 23 March 2021

    Spaces available

    There is widening debate that many of our social, financial and regulatory institutions need to be rethought so that we can create more sustainable futures, particularly in light of the Covid-19 pandemic, the policy/macro-economic response to the pandemic and how it affects consumers, as well as the impending climate crisis. This multi-day series of three keynote webinars, individually presented by leading economist John Kay, Sir Paul Collier, Professor of Economics and Public Policy at the Blavatnik School of Government, Ashok Gupta, Chair at Mercer Ltd, and Nico Aspinall, Chief Investment Officer at B&CE, will open up discussion on these essential topics. The series will culminate in a panel session with Chief Economist of the Bank of England, Andy Haldane.

  • The price is righter

    16 March 2021

    Spaces available

    This webinar provides an overview of the state of the UK protection market, and how different insurers are using different levels of sophistication to price (such as using customer demand models). It considers how insurers have implemented these sophisticated pricing techniques, and the practical challenges they have faced.

  • Spaces available

    This discussion will revolve around the latest industry developments including and introduction to Part VII transfers and Schemes of Arrangement (process, parties involved and recent events), insights and lessons from recent with-profits transactions and restructurings (including Equitable Life and Pru-Rothesay), how firms can apply these learnings to future arrangements, and the outlook for future with-profits transactions and restructurings (including the impacts of Covid-19 and Brexit)


  • Spaces available

    What is stewardship and how has the landscape changed under the 2020 UK Stewardship Code? How does effective stewardship create long term value for beneficiaries and what roles do asset owners and asset managers play in active stewardship. This webinar will offer answers to these questions in a practical approach to stewardship reporting.

  • Spaces available

    Mis-estimation risk is a key element of demographic risk, and past work has focused on mis-estimation risk on a run-off basis.  However, this does not meet the requirements of regulatory regimes like Solvency II, which demands that capital requirements are set through the prism of a finite horizon like one year.  This paper presents a value-at-risk approach to mis-estimation risk suitable for Solvency II work.